Understanding Veniz Xr
Veniz XR 150mg is a pharmaceutical-grade extended-release formulation of venlafaxine hydrochloride, manufactured by Sun Pharmaceuticals Industries for laboratory research applications. As a dual serotonin-norepinephrine reuptake inhibitor (SNRI), this compound enables researchers to investigate neurotransmitter reuptake mechanisms and extended-release drug delivery systems. The formulation utilises controlled-release technology to provide sustained compound availability throughout extended research protocols. Researchers at Stroid UK Shop can examine this compound’s pharmacokinetic properties alongside other pharmaceutical preparations in their laboratory studies.
Laboratory Research Applications
This extended-release venlafaxine formulation proves valuable for studying SNRI mechanisms in neurochemical research models. Scientists can investigate the compound’s effects on monoamine transporter proteins and examine sustained-release pharmacokinetics in controlled laboratory environments. The 150mg dosage strength allows for precise research protocols examining dose-response relationships and bioavailability profiles. Researchers studying pharmaceutical compounds can utilise this preparation to examine extended-release mechanisms and compare sustained delivery profiles against immediate-release formulations. This compound complements research involving other pharmaceutical agents, including selective androgen receptor modulators and bioactive peptides in comprehensive pharmacological investigations.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Compound | Venlafaxine Hydrochloride |
| Dosage Strength | 150mg |
| Formulation Type | Extended-Release Capsule |
| Manufacturer | Sun Pharmaceuticals Industries |
| Product Code | EU11737 |
| Storage Conditions | Room temperature, dry environment |
| Molecular Formula | C₁₇H₂₇NO₂·HCl |
| Research Applications | SNRI mechanism studies, pharmacokinetic research |
Research Compliance Statement
Veniz XR 150mg is supplied exclusively for in-vitro laboratory research applications and is not intended for human consumption, therapeutic use, or any other purpose outside controlled scientific investigation. This pharmaceutical preparation must be handled by qualified researchers in appropriate laboratory facilities following institutional safety protocols. Researchers must ensure compliance with all applicable regulations governing pharmaceutical research compounds and maintain proper documentation of research activities involving this material.
